An ICU study found that alcohol-based hand rub applied after patient care reduced glove bioburden, while staff raised feasibility concerns. Researchers stress that the practice does not replace glove changes or hand hygiene.
|Articles|July 30, 2015
Consumer Reports Looks at How Well Hospitals Prevent Common Infections
Advertisement
Today, on the Centers for Disease Control and Prevention (CDC)'s
The post describes the things that highly rated hospitals have in common, and additional steps that Consumer Reports suggests hospitals take in order to provide the best and safest care for their patients.
Read the full Consumer Reports article at
Advertisement
Related to this article
For International Infection Prevention Week, Infection Control Today explores how prevention connects hospital departments with everyday community life and why infection preventionists (IPs), sterile processing department (SPD), professionals, and environmental services (EVS) teams deserve lasting support.
In honor of Global Handwashing Day, Jamar Shaw, MD, MPH, CIC, explains how applying the WHO 5 Moments to actual care sequences can reduce transmission risks in ambulatory settings.
This week's coverage in Infection Control Today centered on a common thread: the systems, partnerships, and data that let infection prevention teams catch problems before patients are harmed.
What might infection prevention rounds miss when visible conditions dominate the conversation? Tommy Davis, PhD, CMIP, a member of ICT's executive advisory board, makes the case for structured observations of clinical workflows, shared accountability, and greater attention to environmental services staff’s insights.
Artist and designer Matthew Caliman shares how personal loss inspired the Cleanup Crew, a handwashing education project using cartoon faucets, songs, and games to help families revisit an essential health message.
This week in infection prevention: Kenya’s Bundibugyo virus response shows why execution, not just planning, determines outcomes, and France reported the first known human Shamonda virus infection. Our roundup also covers brucellosis, blood donor screening, and long-acting HIV antibody findings from IDWeek 2026.
At IDWeek 2026, Jimmy Chang, PhD, discussed investigational HIV antibodies TMB-365 and TMB-380, explaining their complementary mechanisms, early study findings, and ongoing evaluation as a long-acting maintenance regimen.
Advertisement
Advertisement
Trending on Infection Control Today
1
What Is Shamonda Virus? First Human Case in France and Implications for Infection Prevention
2
ICT Weekly Rounds: Ebola Execution Gaps, a Midge-Borne Virus Jumps to Humans, and IDWeek Findings
3
Jimmy Chang, PhD, Discusses Long-Acting HIV Antibody Therapy at IDWeek 2026
4
Take a Closer Look: Meet the EndoPro-Cam®
5